Isis Pharmaceuticals Conference Call to discuss results of the TV-1102 clinical trial and the ATL / TEVA / Isis relationship. Transcript - Thomson StreetEvents

The Premium Business Information Source™

Thomson StreetEvents

Title:	Isis Pharmaceuticals Conference Call to discuss results of the TV-1102 clinical trial and the ATL / TEVA / Isis relationship. Transcript
Price:	$54.00
Publication Date:	Jul 01, 2008
Source:	Thomson StreetEvents
Report Type:	Transcript
Abstract:	Final Transcript of ISIS conference call or presentation, 1-Jul-08 10:00am ET
Brief Excerpt:	...Good day, everyone, and welcome to the Isis Pharmaceuticals conference call to discuss the Abbott investment in Ibis Biosciences, the recently announced data in the multiple sclerosis antisense drug discovered by Isis and being developed by Teva and ATL and other recent events. Leading the call today for Isis is Dr. Stan Crooke, Isis Chairman and CEO. Dr. Crooke, please go ahead. ...
Word Count:	6364
Length:	13 Pages
Ticker:	ISIS
Time:	10:00am ET
Related Report(s):	Isis Pharmaceuticals Q2 2008 Earnings Conference Call Summary: $54.00 Edited Brief of ISIS earnings conference call or presentation, 7-Aug-08 8:30am ET Isis Pharmaceuticals Q2 2008 Earnings Conference Call Transcript: $54.00 Final Transcript of ISIS earnings conference call or presentation, 7-Aug-08 8:30am ET Isis Pharmaceuticals Conference Call to discuss results of the TV-1102 clinical trial and the ATL / TEVA / Isis relationship. Summary: $54.00 Edited Brief of ISIS conference call or presentation, 1-Jul-08 10:00am ET Isis Pharmaceuticals Q1 2008 Earnings Conference Call Summary: $54.00 Edited Brief of ISIS earnings conference call or presentation, 12-May-08 8:30am ET Isis Pharmaceuticals Q1 2008 Earnings Conference Call Transcript: $54.00 Final Transcript of ISIS earnings conference call or presentation, 12-May-08 8:30am ET FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen - Conference Call Summary: $54.00 Edited Brief of ISIS conference call or presentation, 25-Apr-08 8:00am ET FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen - Conference Call Transcript: $54.00 Final Transcript of ISIS conference call or presentation, 25-Apr-08 8:00am ET Isis Pharmaceuticals Q4 2007 Earnings Conference Call Summary: $54.00 Edited Brief of ISIS earnings conference call or presentation, 13-Mar-08 8:30am ET
Format:	Adobe Acrobat
Free Sample:	Click Here to Download

Enter the keyword(s) which you would like to search for within this document and click "Search"



Price: $54.00

Looking For Something Else?

Search the Alacra Store

Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool. <br/>Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

about us

public company index

private company index

Copyright © 2008 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.